Appointments And Advancements

January 15, 1998

* Alfacell Corp., of Bloomfield, N.J., named to its board Martin Stadler, former chief financial officer of Hoffmann-La Roche Inc.

No Comments

You must login or register in order to post a comment.

India ink: Equillium shares deep in the black after COVID-19 data from partner

Drugs

Although details are yet to come, Equillium Inc.’s chief medical officer, Krishna Polu, told BioWorld that the company will move “urgently and expeditiously” to...

Today's news in brief

BioWorld

BioWorld briefs for Aug. 6.

Potential COVID-19 cell therapy treatments in development

Cell therapy

Biopharma companies that are focused on cell therapies have reported promising clinical trial results in their ability to treat acute respiratory distress...

Celltrion doubles pace for COVID-19 antibody treatment CT-P59

BioWorld

HONG KONG – Incheon, South Korea-based Celltrion Inc. is rapidly advancing CT-P59, its antiviral antibody treatment for the COVID-19 virus, after receiving its...

Glenmark’s phase III favipiravir study finds drug speeds clinical improvement for some patients

Clinical

HONG KONG – Mumbai, India-headquartered Glenmark Pharmaceuticals Ltd. have released statistically significant top-line results from a phase III trial showing that...

Appointments And Advancements

Related Articles

Report Abusive Comment